1. Home
  2. Directory
  3. New Mexico
  4. Las Cruces
  5. Pharmacist
  6. NPI Profile
  7. Prescriptions 1932339421

MS. MELINDA E GUERRERO R.PH.
Prescription History 1932339421
Pharmacist in Las Cruces, NM

NPI Status: Active since July 20, 2009

Contact Information

2300 E LOHMAN AVE
LAS CRUCES, NM
ZIP 88001
Phone: (575) 647-2506
Fax: (575) 647-1933

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. MELINDA E GUERRERO R.PH., an active Pharmacist specialist practicing in Las Cruces, NM. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 276 documented patient claims. Among these therapy options, the most frequently utilized medication is Arexvy, which accounts for 106 claims alone.

Medication Index

A
B
S
No matching medications currently found on file.

Abrysvo

Generic Formulation: Rsv Vacc, Pref A And Pref B/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 62
30-Day Fills 62.0
Days Supply 62
NM State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$322.57

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Arexvy

Generic Formulation: Rsvpref3 Antigen/As01e/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 106
30-Day Fills 106.0
Days Supply 106
NM State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$314.73

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Boostrix Tdap

Generic Formulation: Diphth,pertuss(Acell),tet VacSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 15
NM State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills17.8
Peer Average Days Supply27
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,004.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$66.96

State Avg Cost Per Claim

$68.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 93
30-Day Fills 93.0
Days Supply 93
NM State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills43.8
Peer Average Days Supply55
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 116.3% higher than the standard regional baseline profile for NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $20,093.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$216.06

State Avg Cost Per Claim

$198.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MS. MELINDA E GUERRERO R.PH. provides transparency into local medical care patterns within Las Cruces, NM.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.